News

SightGlass Vision Presents New Data at Academy ’23

CYPRESS 48-Month Efficacy Study, Prof Wolffsohn Visual Experience Study, and Dr. Ho Real-World Clinical Records Review Further Strengthen Evidence Base for DOT 0.2 Spectacle Lenses

Read More

CooperVision: World Sight Day 2023 Fundraising

CooperVision teams around the world are organizing fundraising activities for Optometry Giving Sight’s World Sight Day Challenge.

Read More

CORE Announces Broadest Ever Scientific Program for AAO ‘23

The Centre for Ocular Research & Education (CORE) has announced a multifaceted series of scientific presentations, lectures, and posters for the American Academy of Optometry (AAO) 2023 Annual Meeting, scheduled from October 11-14.

Read More

Be bold with Xavier Garcia

Following the geometric trends, Xavier Garcia introduces the model Apis for those who want to stay away from the classic rectangle!

Read More

OGS Sets $500,000 Fundraising Goal for the 2023 World Sight Day Challenge

With only a few weeks remaining, Optometry Giving Sight (OGS) has announced a $500,000 fundraising goal for its 2023 World Sight Day Challenge.

Read More

Varilux® XR series™ Now Available Across Canada

Essilor launches new consumer campaign showcasing Varilux® XR series™ as the progressive lens of the future.

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Read More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More
1 32 33 34 35 36 399